Investment adviser · CRD 162938

NGN CAPITAL LLC

Exempt reporting adviser (ERA)

Exempt reporting advisers use a shorter Form ADV report. Some adviser-level figures are not reported; fund disclosures appear below when available.

STAMFORD, CT, United States · Form ADV filed Mar 19, 2026

Adviser-level assets, account counts and staffing figures are unavailable in this filing. View the reported fund disclosures below →

Private funds & service providers

7 Private funds

The count excludes feeder funds. Funds in the latest filing appear first, ordered by reported gross assets. Earlier funds retain their last reported values.

NGN BIOMED 2AVenture Capital Fund · Last reported Mar 19, 2026$88.4MGross asset value

Feeder funds

  • NGN BIOMED 2B
Fund administrator SS&C TECHNOLOGIES INC. CRANFORD, New York, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor GRANT THORNTON LLP NEW YORK, New York, United States
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
No
Administrator other than the adviser
Yes
External marketing
No

GRANT THORNTON LLP
PCAOB 248

Fund details & source
Fund ID
805-8873822956
Reported beneficial owners
86
Minimum commitment
$100K
Form D file number
021-112708

Form ADV 2076034 · Mar 19, 2026 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

NGN OPTISCAN FUND I, LPVenture Capital Fund · Last reported Mar 30, 2020$2.27MGross asset value

No provider names available in this fund's imported disclosure.

Provider details
Annual audit
No
Prime brokers
No
Custodians
No
Administrator other than the adviser
No
External marketing
No
Fund details & source
Fund ID
805-4512453833
Reported beneficial owners
14
Minimum commitment
$1

Form ADV 1389031 · Mar 30, 2020 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

NGN OPTISCAN FUND II, LPVenture Capital Fund · Last reported Mar 30, 2020$1.78MGross asset value

No provider names available in this fund's imported disclosure.

Provider details
Annual audit
No
Prime brokers
No
Custodians
No
Administrator other than the adviser
No
External marketing
No
Fund details & source
Fund ID
805-6371452364
Reported beneficial owners
25
Minimum commitment
$1.5K

Form ADV 1389031 · Mar 30, 2020 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

NGN OPTISCAN FUND III, LPVenture Capital Fund · Last reported Mar 30, 2020$1000KGross asset value

No provider names available in this fund's imported disclosure.

Provider details
Annual audit
No
Prime brokers
No
Custodians
No
Administrator other than the adviser
No
External marketing
No
Fund details & source
Fund ID
805-1372523715
Reported beneficial owners
22
Minimum commitment
$1.5K

Form ADV 1389031 · Mar 30, 2020 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

NGN BIOMED OPPORTUNITY ANNEX FUND LPVenture Capital Fund · Last reported Mar 18, 2021$185KGross asset value

Form D fundraising filings

NGN BioMed Opportunity Annex Fund, L.P.

Feeder funds

  • NGN BIOMED OPPORTUNITY ANNEX FUND (GERMAN FEEDER) GMBH & CO KG

No provider names available in this fund's imported disclosure.

Provider details
Annual audit
No
Prime brokers
No
Custodians
No
Administrator other than the adviser
No
External marketing
No
Fund details & source
Fund ID
805-9015880424
Reported beneficial owners
25
Minimum commitment
$100K
Form D file number
021-191133

Form ADV 1494991 · Mar 18, 2021 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

NGN BIOMED 1BVenture Capital Fund · Last reported Mar 20, 2023$43.5KGross asset value
Auditor ALR TREUHAND GMBH MUNICH, Germany
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
No
Administrator other than the adviser
No
External marketing
No
Fund details & source
Fund ID
805-1436780502
Reported beneficial owners
8
Minimum commitment
$1M

Form ADV 1717943 · Mar 20, 2023 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

NGN BIOMED 1AVenture Capital Fund · Last reported Mar 24, 2022$0Gross asset value
Fund administrator SS&C TECHNOLOGIES, INC. CRANFORD, New Jersey, United States Investor statements: Some (provided to some but not all investors) Related to adviser: No
Auditor GRANT THORNTON LLP NEW, New York, United States
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
No
Administrator other than the adviser
Yes
External marketing
No

GRANT THORNTON LLP
PCAOB 248

Fund details & source
Fund ID
805-5936958052
Reported beneficial owners
95
Minimum commitment
$160K
Form D file number
021-65723

Form ADV 1617598 · Mar 24, 2022 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

Services & filing details

Most recent filing: Mar 19, 2026. View historical filings

Reported services

Not reported in these imported fields

Compensation

Not reported in these imported fields

Principal office

60 LONG RIDGE ROAD, SUITE 402
STAMFORD, CT, 06902, United States

CRD 162938

Filing source

Form ADV 2076034 · Mar 19, 2026 · Items 1 & 5

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.